| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |